Keywords: abbott, labs, humira, marks, first, successful, health

Abbott Labs' Humira marks first successful year

Article | 05 January 2004

Print This

US health care major Abbott Laboratories' Humira (adalimumab), a biologic and the first fully-human monoclonal antibody for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in